Paper33816577
Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant.
Hamada M and 3 others. Front Cardiovasc Med, 2021. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant. Papers, record 33816577. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33816577
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33692375 | Identification of an alpha-1 antitrypsin variant with enhanced specificity for factor XIa by phage display, bacterial expression, and combinatorial mutagenesis. | Sci Rep | 2021 | https://conductscience.org/library/papers/33692375 | PubMed |
| 2 | 15829482 | Exosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15829482 | PubMed |
| 3 | 23996272 | How good is automated protein docking? | Proteins | 2013 | https://conductscience.org/library/papers/23996272 | PubMed |
| 4 | 16176258 | Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans. | FEBS J | 2005 | https://conductscience.org/library/papers/16176258 | PubMed |
| 5 | 21778227 | The role of factor XIa (FXIa) catalytic domain exosite residues in substrate catalysis and inhibition by the Kunitz protease inhibitor domain of protease nexin 2. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21778227 | PubMed |
| 6 | 27789479 | Design and characterization of an APC-specific serpin for the treatment of hemophilia. | Blood | 2017 | https://conductscience.org/library/papers/27789479 | PubMed |
| 7 | 8439290 | Evolutionary families of peptidases. | Biochem J | 1993 | https://conductscience.org/library/papers/8439290 | PubMed |
| 8 | 7592834 | Coagulation factor XIa cleaves the RHDS sequence and abolishes the cell adhesive properties of the amyloid beta-protein. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7592834 | PubMed |
| 9 | 16321984 | Active site distortion is sufficient for proteinase inhibition by serpins: structure of the covalent complex of alpha1-proteinase inhibitor with porcine pancreatic elastase. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16321984 | PubMed |
| 10 | 21057700 | Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis. | Thromb Haemost | 2011 | https://conductscience.org/library/papers/21057700 | PubMed |
| 11 | 19617576 | Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. | Blood | 2009 | https://conductscience.org/library/papers/19617576 | PubMed |
| 12 | 27936493 | New additions to the ClusPro server motivated by CAPRI. | Proteins | 2017 | https://conductscience.org/library/papers/27936493 | PubMed |
| 13 | 16085935 | Structural and mutational analyses of the molecular interactions between the catalytic domain of factor XIa and the Kunitz protease inhibitor domain of protease nexin 2. | J Biol Chem | 2005 | https://conductscience.org/library/papers/16085935 | PubMed |
| 14 | 31366623 | Design and characterization of α1-antitrypsin variants for treatment of contact system-driven thromboinflammation. | Blood | 2019 | https://conductscience.org/library/papers/31366623 | PubMed |
| 15 | 16931632 | Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII. | Blood | 2006 | https://conductscience.org/library/papers/16931632 | PubMed |
| 16 | 24977287 | Antigen levels of coagulation factor XII, coagulation factor XI and prekallikrein, and the risk of myocardial infarction and ischemic stroke in young women. | J Thromb Haemost | 2014 | https://conductscience.org/library/papers/24977287 | PubMed |
| 17 | 21781239 | Serpin structure, function and dysfunction. | J Thromb Haemost | 2011 | https://conductscience.org/library/papers/21781239 | PubMed |
| 18 | 1888745 | Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate. | Biochemistry | 1991 | https://conductscience.org/library/papers/1888745 | PubMed |
| 19 | 7534133 | Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor. | Blood | 1995 | https://conductscience.org/library/papers/7534133 | PubMed |
| 20 | 32268028 | Alpha1-Antitrypsin Deficiency. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32268028 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40607491 | Expression and purification of a broad-spectrum human protease inhibitor in Pichia pastoris. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/40607491 | PubMed |
| 40075385 | Enhancement of plasma kallikrein specificity of antitrypsin variants identified by phage display and partial reversion. | BMC Biotechnol | 2025 | https://conductscience.org/library/papers/40075385 | PubMed |
| 39441778 | Prolonging the circulatory half-life of C1 esterase inhibitor via albumin fusion. | PLoS One | 2024 | https://conductscience.org/library/papers/39441778 | PubMed |
| 37158379 | The under-appreciated world of the serpin family of serine proteinase inhibitors. | EMBO Mol Med | 2023 | https://conductscience.org/library/papers/37158379 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33816577
GET https://conductscience.org/api/papers/v1/33816577/references?page=2